100
Participants
Start Date
August 4, 2022
Primary Completion Date
December 3, 2024
Study Completion Date
December 3, 2024
Colchicine Pill
Anti-inflammatory
Placebo
Inert ingredients
University of Calgary, Foothills Medical Centre, Calgary
University of Alberta, Edmonton
University of British Columbia, Vancouver
Kingston General Hospital, Kingston Health Sciences, Kingston
London Health Science Centre, University Hospital, London
Ottawa Hospital Research Institute, Ottawa
Sunnybrook Hospital, Toronto
Toronto Western Hospital, Toronto
University of Montreal, Montreal
University of Saskatchewan, Saskatoon
Hamilton General Hospital, Hamilton Health Sciences, Hamilton
Lead Sponsor
Population Health Research Institute
OTHER